Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04087421

Comparison of Transanal Irrigation and Glycerol Suppositories in Treatment of Low Anterior Resection Syndrome

Comparison of Transanal Irrigation and Glycerol Suppositories in Treatment of Low Anterior Resection Syndrome: A Multicentre Randomised Controlled Trial

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
114 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The study is a multicentre randomized controlled trial with the objective to compare the effect of transanal irrigation with glycerol suppositories in patients suffering from major Low Anterior Resection Syndrome (LARS).

Detailed description

Transanal irrigation (TAI) is used as a second-line treatment following unsuccessful personalised conservative treatment (PCT) of LARS. However, it is unknown if scheduled, initiated defecation with the aid of a glycerol suppository will have the same clinical effect as TAI. Thus, the aim of this study is to compare the effect of TAI with a glycerol suppository in patients suffering from major LARS. The study is a multi-centre, randomised, controlled, 12 weeks, parallel-group trial comparing treatment with TAI to treatment with glycerol suppositories. Patients will be randomised - stratified by centre and neoadjuvant radiotherapy - in a 1:1 ratio to receive treatment with TAI or glycerol suppositories. Primary endpoint will be assessed by the end of week twelve.

Conditions

Interventions

TypeNameDescription
DEVICEQufora Irrisedo Cone SystemThe system works by connecting a tube from a water bag to a cone. The cone is placed into the rectum and the prescribed water volume is pumped into the rectum. When the water has been installed the valve is closed and the cone removed. Residual water and stool will then flow into the toilet.
DRUGGlycerol "OBA"Rectal suppository. Stimulates the rectum and softens and loosens stool.

Timeline

Start date
2019-09-17
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2019-09-12
Last updated
2023-05-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04087421. Inclusion in this directory is not an endorsement.